A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intramorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000)

Ganly, I Kirn, D Eckhardt, SG Rodriguez, GI Soutar, DS Otto, R Robertson, AG Park, O Gulley, ML Heise, C VonHoff, DD Kaye, SB

I. Ganly et al., A Phase I study of Onyx-015, an E1B attenuated adenovirus, administered intramorally to patients with recurrent head and neck cancer (vol 6, pg 798, 2000), CLIN CANC R, 6(9), 2000, pp. 3797-3797

1

Oncology

CLINICAL CANCER RESEARCH

10780432 → ACNP

6

9

2000

3797 - 3797

ISI

1078-0432(200009)6:9<3797:APISOO>2.0.ZU;2-E